nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—Hepatic failure—Progesterone—uterine cancer	0.0429	0.0429	CcSEcCtD
Fospropofol—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.0389	0.0389	CcSEcCtD
Fospropofol—Tingling sensation—Etoposide—uterine cancer	0.0338	0.0338	CcSEcCtD
Fospropofol—Apnoea—Etoposide—uterine cancer	0.0321	0.0321	CcSEcCtD
Fospropofol—Pain—Carboplatin—uterine cancer	0.0309	0.0309	CcSEcCtD
Fospropofol—Hepatic failure—Dactinomycin—uterine cancer	0.0304	0.0304	CcSEcCtD
Fospropofol—Angiopathy—Progesterone—uterine cancer	0.0242	0.0242	CcSEcCtD
Fospropofol—Mediastinal disorder—Progesterone—uterine cancer	0.0241	0.0241	CcSEcCtD
Fospropofol—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.0219	0.0219	CcSEcCtD
Fospropofol—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0218	0.0218	CcSEcCtD
Fospropofol—Cough—Progesterone—uterine cancer	0.0203	0.0203	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.0197	0.0197	CcSEcCtD
Fospropofol—Stinging—Epirubicin—uterine cancer	0.0188	0.0188	CcSEcCtD
Fospropofol—Nervous system disorder—Progesterone—uterine cancer	0.0186	0.0186	CcSEcCtD
Fospropofol—Skin disorder—Progesterone—uterine cancer	0.0184	0.0184	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.0178	0.0178	CcSEcCtD
Fospropofol—Hypotension—Progesterone—uterine cancer	0.0177	0.0177	CcSEcCtD
Fospropofol—Stinging—Doxorubicin—uterine cancer	0.0174	0.0174	CcSEcCtD
Fospropofol—Paraesthesia—Progesterone—uterine cancer	0.017	0.017	CcSEcCtD
Fospropofol—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0169	0.0169	CcSEcCtD
Fospropofol—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.0167	0.0167	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Progesterone—uterine cancer	0.0164	0.0164	CcSEcCtD
Fospropofol—Pain—Progesterone—uterine cancer	0.0162	0.0162	CcSEcCtD
Fospropofol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0161	0.0161	CcSEcCtD
Fospropofol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0154	0.0154	CcSEcCtD
Fospropofol—Ventricular tachycardia—Epirubicin—uterine cancer	0.0152	0.0152	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0148	0.0148	CcSEcCtD
Fospropofol—Ventricular tachycardia—Doxorubicin—uterine cancer	0.0141	0.0141	CcSEcCtD
Fospropofol—Pruritus—Progesterone—uterine cancer	0.0134	0.0134	CcSEcCtD
Fospropofol—Angiopathy—Etoposide—uterine cancer	0.0124	0.0124	CcSEcCtD
Fospropofol—Hepatic failure—Epirubicin—uterine cancer	0.0123	0.0123	CcSEcCtD
Fospropofol—Mediastinal disorder—Etoposide—uterine cancer	0.0123	0.0123	CcSEcCtD
Fospropofol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Fospropofol—Vomiting—Progesterone—uterine cancer	0.0121	0.0121	CcSEcCtD
Fospropofol—Headache—Progesterone—uterine cancer	0.0119	0.0119	CcSEcCtD
Fospropofol—Pain—Dactinomycin—uterine cancer	0.0115	0.0115	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—uterine cancer	0.0114	0.0114	CcSEcCtD
Fospropofol—Nausea—Progesterone—uterine cancer	0.0113	0.0113	CcSEcCtD
Fospropofol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0109	0.0109	CcSEcCtD
Fospropofol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0108	0.0108	CcSEcCtD
Fospropofol—Cough—Etoposide—uterine cancer	0.0104	0.0104	CcSEcCtD
Fospropofol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0102	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.0101	0.0101	CcSEcCtD
Fospropofol—Skin disorder—Etoposide—uterine cancer	0.00942	0.00942	CcSEcCtD
Fospropofol—Hypotension—Etoposide—uterine cancer	0.00907	0.00907	CcSEcCtD
Fospropofol—Paraesthesia—Etoposide—uterine cancer	0.00871	0.00871	CcSEcCtD
Fospropofol—Vomiting—Dactinomycin—uterine cancer	0.00852	0.00852	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Etoposide—uterine cancer	0.00838	0.00838	CcSEcCtD
Fospropofol—Pain—Etoposide—uterine cancer	0.0083	0.0083	CcSEcCtD
Fospropofol—Nausea—Dactinomycin—uterine cancer	0.00796	0.00796	CcSEcCtD
Fospropofol—Angiopathy—Epirubicin—uterine cancer	0.00695	0.00695	CcSEcCtD
Fospropofol—Mediastinal disorder—Epirubicin—uterine cancer	0.0069	0.0069	CcSEcCtD
Fospropofol—Pruritus—Etoposide—uterine cancer	0.00686	0.00686	CcSEcCtD
Fospropofol—Angiopathy—Doxorubicin—uterine cancer	0.00643	0.00643	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—uterine cancer	0.00638	0.00638	CcSEcCtD
Fospropofol—Vomiting—Etoposide—uterine cancer	0.00617	0.00617	CcSEcCtD
Fospropofol—Headache—Etoposide—uterine cancer	0.00608	0.00608	CcSEcCtD
Fospropofol—Cough—Epirubicin—uterine cancer	0.00582	0.00582	CcSEcCtD
Fospropofol—Nausea—Etoposide—uterine cancer	0.00576	0.00576	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00563	0.00563	CcSEcCtD
Fospropofol—Cough—Doxorubicin—uterine cancer	0.00538	0.00538	CcSEcCtD
Fospropofol—Nervous system disorder—Epirubicin—uterine cancer	0.00533	0.00533	CcSEcCtD
Fospropofol—Skin disorder—Epirubicin—uterine cancer	0.00528	0.00528	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00521	0.00521	CcSEcCtD
Fospropofol—Hypotension—Epirubicin—uterine cancer	0.00508	0.00508	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—uterine cancer	0.00494	0.00494	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—uterine cancer	0.00489	0.00489	CcSEcCtD
Fospropofol—Paraesthesia—Epirubicin—uterine cancer	0.00488	0.00488	CcSEcCtD
Fospropofol—Hypotension—Doxorubicin—uterine cancer	0.0047	0.0047	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.0047	0.0047	CcSEcCtD
Fospropofol—Pain—Epirubicin—uterine cancer	0.00465	0.00465	CcSEcCtD
Fospropofol—Paraesthesia—Doxorubicin—uterine cancer	0.00452	0.00452	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00434	0.00434	CcSEcCtD
Fospropofol—Pain—Doxorubicin—uterine cancer	0.0043	0.0043	CcSEcCtD
Fospropofol—Pruritus—Epirubicin—uterine cancer	0.00385	0.00385	CcSEcCtD
Fospropofol—Pruritus—Doxorubicin—uterine cancer	0.00356	0.00356	CcSEcCtD
Fospropofol—Vomiting—Epirubicin—uterine cancer	0.00346	0.00346	CcSEcCtD
Fospropofol—Headache—Epirubicin—uterine cancer	0.00341	0.00341	CcSEcCtD
Fospropofol—Nausea—Epirubicin—uterine cancer	0.00323	0.00323	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—uterine cancer	0.0032	0.0032	CcSEcCtD
Fospropofol—Headache—Doxorubicin—uterine cancer	0.00315	0.00315	CcSEcCtD
Fospropofol—Nausea—Doxorubicin—uterine cancer	0.00299	0.00299	CcSEcCtD
